The present invention relates to medical domains. More specifically, this disclosure relates to the joint of the antibody in conjunction with the antibody and combination 1 ligand 1 of peoples apoptosis (PD-L1) of colony-stimulating factor 1 receptor (CSF-1R), and it is related to the method using the combination therapy cancer and the especially solid tumor with macrophages infiltration.